Business Valuation Zone

Eiger Gets Deal With Merck Over $46M Rare-Disease Drug Sale

Law 360 M&A

MAY 1, 2024

Bankrupt Eiger BioPharmaceuticals Inc. told a Texas federal judge Wednesday it had struck a tentative agreement with drug company Merck & Co. over licensing rights to a rare-disease drug that it is selling for $46.1

Cancer-Focused Imago BioSciences Shares Soar After Merck Deal

Benzinga

NOVEMBER 21, 2022

Merck & Co Inc (NYSE: MRK ) has agreed to acquire Imago BioSciences Inc (NASDAQ: IMGO ) for $36.00 "This acquisition of Imago augments our pipeline and strengthens our presence in the growing field of hematology," commented Merck's President & CEO, Robert Davis.

Equity

Equity Marketability

Ex-Biopharma CEO Sues For Post-Sale Share Appraisal In Del.

Law 360 M&A

MARCH 12, 2024

The co-founder of Caraway Therapeutics Inc. sued in Delaware's Court of Chancery on Tuesday for an appraisal of his shares following the company's November merger with a subsidiary of pharmaceutical giant Merck, alleging that it "was an unfair cash-out transaction" and that he is owed at least a million more shares.

Appraisal

Merck Acquires Prometheus Biosciences For $10.8B, Strengthening Its Immunology Pipeline

Benzinga

APRIL 17, 2023

Prometheus Biosciences Inc (NASDAQ: RXDX ) shares are jumping Monday morning as Merck & Co (NYSE: MRK ) has agreed to acquire the company for $200.00 per share in cash for a total equity value of ~$10.8 The transaction represents over 75% premium to Prometheus' last closing price of $114.01.

Equity

Equity Marketability

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill

Benzinga

JULY 7, 2022

Merck's Potential Buyout Of Seagen Expected Within Next Few Weeks. Merck & Co Inc. NYSE: MRK ) is in advanced talks to acquire Seagen Inc. The FDA placed a clinical hold on DiaMedica Therapeutics Inc.'s NASDAQ: SGEN ). FDA Institutes Clinical Hold On DiaMedica's Late-Stage Stroke Trial.

New Jersey Court: War Exclusion Does Not Bar Coverage for Cyberattack

Mogin Rubin M&A

JANUARY 28, 2022

Companies seeking insurance coverage for losses from cyberattacks received good news this month. The New Jersey Superior Court for Union County found that Merck & Co., billion insurance policy with ACE American Insurance Company (now The Chubb Corporation) is not barred by the policy’s war exclusion clause.

The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid

Benzinga

APRIL 29, 2022

The FDA has approved Bristol Myers Squibb & Co's (NYSE: BMY ) Camzyos (mavacamten) for obstructive hypertrophic cardiomyopathy (obstructive HCM) to improve functional capacity and symptoms. Back-To-Back European Approval For Merck's Keytruda In Various Cancer Indications. Stocks In Focus. Zymeworks Confirms $10.50/Share

MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022

Benzinga

JULY 17, 2023

MoonLake Immunotherapeutics (NASDAQ: MLTX ) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for inflammatory skin conditions. The is in preliminary talks with pharmaceutical companies interested in a potential acquisition.

Banking

Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge

Benzinga

FEBRUARY 23, 2023

MEI Pharma Inc (NASDAQ: MEIP ) and Infinity Pharmaceuticals Inc (NASDAQ: INFI ) have entered into a definitive merger agreement for an all-stock transaction forming a company focusing on three clinical-stage oncology drug candidates.

Merck's $1.35B Merger With Biotech Faces Investor Suits

Law 360 M&A

DECEMBER 14, 2022

Imago Biosciences got hit with three investor actions in as many days this week, alleging it sent out solicitation statements with missing financial information to shareholders evaluating tender offers they received as part of the company's pending $1.35 billion acquisition by Merck & Co.

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate

Benzinga

AUGUST 4, 2022

AstraZeneca/Merck's Lynparza Scores European Approval In Early Breast Cancer. The European Medicines Agency issued a positive opinion on Syros Pharmaceuticals Inc (NASDAQ: SYRS )'s application for orphan drug designation for tamibarotene for myelodysplastic syndrome (MDS). The FDA recommends the company pursue traditional.

Finance

Sugar Alcohol Market to Hit USD 6.70 Billion by 2027 | Exhibiting a CAGR of 7.75%

Benzinga

DECEMBER 7, 2022

Rising support from governments and several companies can help in the fight against this highly contagious disease. List of the Companies Operating in the Sugar Alcohol Market: Archer-Daniels-Midland Co. Pfizer Inc. – Merck KGaA – German. However, this too shall pass. Illinois, U.S. Cargill Incorporated – U.S.

Marketability

Chondroitin Sulfate Market to grow at a 3.4% CAGR - MDC Research

Benzinga

APRIL 21, 2022

COMPANY PROFILES (Business Overview, Products Offered, Financial Performance, Recent Developments)* Bioiberica S.A.U. Sigma-Aldrich (Merck KGaA). Sioux Pharm, Inc. Jiaxing Hengjie Biopharmaceutical Co., Synutra, Inc. PACIFIC RAINBOW INTERNATIONAL, INC. Download Sample PDF [link]. ZPD (Zeria Group).

Marketability

Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.

Benzinga

NOVEMBER 10, 2022

10, 2022 (GLOBE NEWSWIRE) -- Yumanity Therapeutics, Inc. Yumanity" or the "Company") (NASDAQ: YMTX ) today announced that the registration statement on Form S-4 (the "Registration Statement"), relating to the previously announced asset sale to Janssen Pharmaceutica NV ("Janssen") and merger with Kineta, Inc. BOSTON, Nov.

Dividends

Dividends Banking Equity

Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing

Benzinga

NOVEMBER 18, 2022

Before joining Integra in 1999, he served on the accounting standards team at Merck & Co., a publicly traded healthcare company. Rice joined Orthofix in 2014 and was instrumental in building talented teams and accelerating the company's strategic growth. Orthofix Medical Inc. Orthofix Medical Inc.

Technology

Technology Marketability

Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ

Benzinga

AUGUST 31, 2022

The combined company is designed to have a diversified pipeline with multiple ‘shots-on-goal' across varying indications and therapeutic areas, built from relationships with leading research institutions. The combined company will be renamed "Ocean Biomedical, Inc." NEW YORK, Aug.

Enterprise Value

Enterprise Value Technology Marketability

Gibson Dunn Offers 2022 Mid-Year Securities Litigation Update

Reynolds Holding

OCTOBER 5, 2022

Lucia Companies, Inc. Lee Enterprises, Inc. CytoDyn Inc. 13, 2021), which we discussed in our 2021 Year-End Securities Litigation Update, the court declined to apply both the stringent review of Blasius Industries, Inc. Mesa Petroleum Co. , UIP Companies, Inc. Chris-Craft Industries, Inc. ,

Start-ups

Start-ups Marketability Equity Compliance

AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V

Benzinga

OCTOBER 20, 2022

Company to expand US operations and clinical programs. AUM"), a clinical-stage biotechnology company, advancing a clinical stage pipeline designed to deploy multi-faceted inhibition strategies to reverse cancer resistance, and Mountain Crest Acquisition Corp. SINGAPORE and NEW YORK, Oct. AUM Investment Highlights.

Equity

Equity Marketability

SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19

Benzinga

OCTOBER 19, 2022

senators inspecting antitrust issues are set to hold a hearing on grocery chain Kroger Co's (NYSE: KR ) plan to acquire rival Albertsons Companies Inc (NYSE: ACI ) in a $25 billion deal. Amazon.com Inc (NASDAQ: AMZN ) was handed a fine by a court in Russia for failing to remove proscribed content on Tuesday.

Marketability

Business Valuation Zone

Eiger Gets Deal With Merck Over $46M Rare-Disease Drug Sale

Cancer-Focused Imago BioSciences Shares Soar After Merck Deal

Trending Sources

Ex-Biopharma CEO Sues For Post-Sale Share Appraisal In Del.

Merck Acquires Prometheus Biosciences For $10.8B, Strengthening Its Immunology Pipeline

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill

New Jersey Court: War Exclusion Does Not Bar Coverage for Cyberattack

The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid

MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022

Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge

Merck's $1.35B Merger With Biotech Faces Investor Suits

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate

Sugar Alcohol Market to Hit USD 6.70 Billion by 2027 | Exhibiting a CAGR of 7.75%

Chondroitin Sulfate Market to grow at a 3.4% CAGR - MDC Research

Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.

Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing

Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ

Gibson Dunn Offers 2022 Mid-Year Securities Litigation Update

AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V

SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19

Stay Connected